Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2023-07-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Short-term Oxygen During CPET in COPD
NCT03196089
Effect of Short-term Oxygen During CPET in Pulmonary Hypertension
NCT01748474
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance
NCT02143687
Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases
NCT06385301
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
NCT06053164
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxygen
Supplemental oxygen will be applied via a mask during CPET
Incremental exercise test (IET)
Incremental cardio pulmonary exercise test until exhaustion
Constant work rate exercise test (CWRET)
constant (on 75% Wmax) cardio pulmonary exercise test until exhaustion
Air
Sham ambient air will be applied via mask during CPET
Incremental exercise test (IET)
Incremental cardio pulmonary exercise test until exhaustion
Constant work rate exercise test (CWRET)
constant (on 75% Wmax) cardio pulmonary exercise test until exhaustion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Incremental exercise test (IET)
Incremental cardio pulmonary exercise test until exhaustion
Constant work rate exercise test (CWRET)
constant (on 75% Wmax) cardio pulmonary exercise test until exhaustion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FEV1/FVC \>70% and FVC \<85% predicted
* stable medication for at least 4 weeks
* Desaturation in SpO2 in 6-minute walk test of ≥ 4% to absolute values ≤ 92%
* Signed Informed Consent
* Male and female patients 18 to 80 years of age
Exclusion Criteria
* Other clinically significant concomitant disease states (e.g., cardiovascular disease, hepatic dysfunction, etc)
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state of the subject, neurological or orthopaedic problems with walking disability or inability to ride a bicycle
* Women who are pregnant or breast feeding
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Respiratory Clinic, University Hospital of Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-NR. 2012-0251_5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.